ALK and T-cell non-Hodgkin lymphoma: Our study evaluated the serum levels of cytokines, especially Th2-associated cytokines, and analyzed their association with survival outcome in patients with nodal T-cell lymphomas including AITL, PTCL-NOS, and ALK+/- ALCL.